Eli Lilly Co. to buy gene-editing startup Verve to develop cardiac drugs

Eli Lilly will buy Boston-based Verve Therapeutics, Inc. in a billion dollar deal with plans to advance Verve's new line of experimental cardiac health drugs. ...[TheTopNews] Read More.